Patients News | pharmaphorum

News

Forget the doctor, why not just ask ChatGPT?

In a study of random patient questions drawn from the Reddit social media platform, people responded more positively to answers provided by

News

NICE backs use of Gilead/Kite CAR-T via Cancer Drugs Fund

A pair of new guidance documents from UK cost-effectiveness authority NICE could see hundreds of more blood cancer patients eligible for treatment with CAR-T therapies fro

News

Single market at heart of EU plans for pharma reform

The European Commission’s long-promised revamp of pharmaceutical legislation is finally unveiled, and it’s ambitious to say the least.

News

Nerve damage-tracking pen to be used in CAR-T patients

Nerve damage is a recognised side effect of some CAR-T therapies for cancer, and one that could be spotted early using a pen device developed by UK company Manus Neurodyna

News

Supreme Court presses pause on mifepristone curbs

The US Supreme Court has said it will allow the abortion pill mifepristone to remain available while an appeal of the decision to strike down its regulatory approval make

News

US senators unveil their PBM reform plan

Senior lawmakers in the US across both sides of the political divide have released a list of measures that they are considering to reduce medicine costs for patients and t

Forget the doctor, why not just ask ChatGPT?

NICE backs use of Gilead/Kite CAR-T via Cancer Drugs Fund

Single market at heart of EU plans for pharma reform

Nerve damage-tracking pen to be used in CAR-T patients

Supreme Court presses pause on mifepristone curbs

US senators unveil their PBM reform plan

Amazon puts $100m into global health drive

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks